PHIO PHIO PHARMACEUTICALS CORP Management Changes 8-K Filing 2024 - Appointment of Chief Financial Officer Phio Pharmaceuticals Corp. appoints Robert M. Infarinato as Vice President and Chief Financial Officer, effective August 1, 2024.Get access to all SEC 8-K filings of the PHIO PHARMACEUTICALS CORP